Display options
Share it on

Hip Pelvis. 2018 Dec;30(4):197-201. doi: 10.5371/hp.2018.30.4.197. Epub 2018 Dec 06.

Deep Vein Thrombosis Prophylaxis after Total Hip Arthroplasty in Asian Patients.

Hip & pelvis

Jun-Shik Kim

Affiliations

  1. The Joint Replacement Center, Ewha Womans University Medical Center, Seoul, Korea.

PMID: 30534537 PMCID: PMC6284075 DOI: 10.5371/hp.2018.30.4.197

Abstract

In Western patient populations, the reported incidence of imaging-demonstrated deep vein thrombosis (DVT) after total hip arthroplasty (THA) is as high as 70% without prophylaxis. The reported rates of symptomatic pulmonary embolism (PE) after THA in recent studies range from 0.6% to 1.5%, and the risk of fatal PE ranges from 0.11% to 0.19% in the absence of prophylaxis. Predisposing factors to DVT in western patients include advanced age, previous venous insufficiency, osteoarthritis, obesity, hyperlipidemia, dietary and genetic factors. However, Asian patients who have undergone THA have a strikingly low prevalence of DVT and virtually no postoperative PE. Some authors suggest low clinical prothrombotic risk factors and the absence of some DVT-related genetic factors in Asian patient populations decrease the risk of DVT, PE or both. In Korea, the prevalence of DVT after THA without thromboprophylaxis have ranges from 6.8% to 43.8%, and asymptomatic PE have ranges from 0% to 12.9%; there have been only two reported cases of fatal PE. Deep-wound infections resulting from postoperative hematomas or prolonged wound drainage have been reported with routine thromboprophylaxis. The prevalence of DVT differs varies based on patient ethnicity. Guidelines for the use of thromboprophylaxis were altered and focus on the potential value of outcomes compared with possible complications (e.g., bleeding).

Keywords: Asians; Deep vein thrombosis; Prophylaxis; Pulmonary embolism; Total hip arthroplasty

Conflict of interest statement

CONFLICT OF INTEREST: The author declares that there is no potential conflict of interest relevant to this article.

References

  1. Clin Orthop Relat Res. 1977;(127):123-32 - PubMed
  2. Orthopedics. 1994 Jul;17 Suppl:8-10 - PubMed
  3. Lancet. 1974 Oct 5;2(7884):797-800 - PubMed
  4. Thromb Haemost. 1999 May;81(5):739-44 - PubMed
  5. J Bone Joint Surg Br. 1997 Nov;79(6):896-9 - PubMed
  6. Blood. 1998 Aug 15;92(4):1119-24 - PubMed
  7. Thromb Haemost. 2002 Apr;87(4):580-5 - PubMed
  8. J Bone Joint Surg Am. 2000 Jul;82-A(7):929-38 - PubMed
  9. J Bone Joint Surg Am. 1971 Oct;53(7):1271-80 - PubMed
  10. J Bone Joint Surg Am. 2002 Dec;84-A(12):2161-7 - PubMed
  11. Am J Cardiol. 2000 Jun 1;85(11):1334-7 - PubMed
  12. Clin Orthop Relat Res. 1996 Dec;(333):27-40 - PubMed
  13. Chest. 2004 Sep;126(3 Suppl):287S-310S - PubMed
  14. Clin Orthop Relat Res. 2005 Dec;441:40-55 - PubMed
  15. Clin Orthop Relat Res. 2007 Dec;465:33-9 - PubMed
  16. Pathology. 1997 Aug;29(3):263-6 - PubMed
  17. Br J Surg. 1980 Apr;67(4):251-3 - PubMed
  18. J Bone Joint Surg Br. 1996 Nov;78(6):863-70 - PubMed
  19. Chest. 2008 Jun;133(6 Suppl):381S-453S - PubMed
  20. J Arthroplasty. 2007 Sep;22(6 Suppl 2):24-8 - PubMed
  21. J Arthroplasty. 2005 Apr;20(3):273-4 - PubMed
  22. Am J Orthop (Belle Mead NJ). 2007 Sep;36(9 Suppl):11-3 - PubMed
  23. Int J Cardiol. 1988 Sep;20(3):373-80 - PubMed
  24. Chest. 2012 Feb;141(2 Suppl):e278S-e325S - PubMed
  25. J Long Term Eff Med Implants. 2007;17(4):359-65 - PubMed
  26. Br J Haematol. 1980 Dec;46(4):603-12 - PubMed
  27. J Am Acad Orthop Surg. 2017 Dec;25(12):789-798 - PubMed
  28. BMJ. 1992 Sep 5;305(6853):567-74 - PubMed
  29. Lancet. 1975 Jun 21;1(7921):1357-8 - PubMed
  30. Clin Orthop Relat Res. 2011 Dec;469(12):3423-8 - PubMed
  31. J Bone Joint Surg Br. 2003 Jul;85(5):661-5 - PubMed
  32. J Bone Joint Surg Am. 1993 Jun;75(6):893-8 - PubMed
  33. J Bone Joint Surg Am. 2007 Jan;89(1):33-8 - PubMed

Publication Types